Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $40.7727.
A number of brokerages have recently weighed in on ACHC. Royal Bank Of Canada dropped their price target on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. UBS Group dropped their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Barclays reduced their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Finally, Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th.
Read Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Stock Up 1.4%
Shares of ACHC stock traded up $0.32 on Wednesday, hitting $23.65. The stock had a trading volume of 3,011,880 shares, compared to its average volume of 2,216,774. The stock's 50 day moving average is $22.14 and its 200-day moving average is $25.17. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of 15.66, a P/E/G ratio of 4.52 and a beta of 0.89. Acadia Healthcare has a 52-week low of $17.13 and a 52-week high of $79.82.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the prior year, the company posted $0.91 EPS. Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.
Institutional Investors Weigh In On Acadia Healthcare
Several institutional investors have recently bought and sold shares of ACHC. Allworth Financial LP increased its stake in Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company's stock valued at $31,000 after buying an additional 1,177 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after buying an additional 497 shares in the last quarter. UMB Bank n.a. boosted its stake in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after acquiring an additional 1,234 shares during the last quarter. Finally, State of Wyoming acquired a new stake in Acadia Healthcare during the fourth quarter valued at approximately $56,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.